Valuation: Invent Medic Sweden AB

Market Cap 149M 14.97M 13.37M 12.35M 11.19M 20.94M 1.42B 21.29M 58.85M 745M 56.2M 55M 2.35B P/E 2024
-7.45x
P/E 2025 -16.4x
Enterprise Value 149M 15.05M 13.44M 12.42M 11.25M 21.05M 1.43B 21.4M 59.16M 749M 56.49M 55.29M 2.36B EV / Sales 2024
8.16x
EV / Sales 2025 12.4x
Free-Float
76.16%
Yield 2024 *
-
Yield 2025 -
3 years 0.49
Extreme 0.487
1
5 years 0.24
Extreme 0.243
2.19
10 years 0.24
Extreme 0.243
33.9
Manager TitleAgeSince
Chief Executive Officer - 2025-02-28
Director TitleAgeSince
Chairman 71 2010-02-28
Chairman 73 2020-12-31
Director/Board Member - 2021-04-30
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%-.--%-.--%+10.22% 14.97M
+1.16%-1.13%-18.25%+9.38% 179B
+0.02%+4.24%-19.55%+15.88% 118B
-1.22%+0.70%+1.86%+32.59% 117B
+2.29%+17.36%-42.18%+8.22% 93.26B
-2.21%-2.91%-0.51%+75.12% 63.16B
-1.06%+1.75%+13.48%+74.12% 55.68B
-0.75%+3.73%+7.04%-23.26% 54.18B
-1.13%+0.00%-12.56%+30.09% 44.15B
+0.17%+5.85%-5.20%-11.43% 33.95B
Average -0.20%+3.57%-7.59%+22.09% 75.84B
Weighted average by Cap. -0.00%+3.09%-11.77%+21.99%

Financials

2024 2025
Net sales 7.35M 740K 661K 610K 553K 1.03M 70.24M 1.05M 2.91M 36.8M 2.78M 2.72M 116M 7.4M 746K 666K 615K 558K 1.04M 70.8M 1.06M 2.93M 37.1M 2.8M 2.74M 117M
Net income -7.65M -771K -688K -636K -576K -1.08M -73.17M -1.1M -3.03M -38.34M -2.89M -2.83M -121M -5.2M -524K -468K -432K -392K -733K -49.74M -745K -2.06M -26.06M -1.97M -1.92M -82.15M
Net Debt 3.46M 349K 311K 288K 261K 488K 33.09M 496K 1.37M 17.34M 1.31M 1.28M 54.67M 783K 78.85K 70.41K 65.05K 58.95K 110K 7.49M 112K 310K 3.92M 296K 290K 12.36M
Projected Income Statement - Annual - Invent Medic Sweden AB
Logo Invent Medic Sweden AB
Invent Medic Sweden AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company manufactures TVS that is a medical device for non-surgical treatment of female stress urinary incontinence. The product has a similar mechanism of action as the surgical treatment method. Effect time-mechanism is based on two parts with the upper annular support incontinence in the upper part of the urethra while the lower part comprises an external fixation plate that ensures that the TVS placed correctly. Following the introduction of the product is the labia range around the reference part to ensure that the supporting part is always positioned correctly in order to exert its effect.
Employees
6